Dishman Carbogen Amcis Limited is a global pharmaceutical company that provides contract research, development, and manufacturing services for drug substances and specialty chemicals, supporting pharmaceutical and biotech clients from early-stage research to commercial production, with headquarters in Ahmedabad, India and operations across India, Europe, and Asia.
Key Management Personnel
Janmejay R. Vyas
Founder & Chairman
View all team
Secondary market activity
27 Jan 202613 Oct 2026
1M3M6M1YAll
Last trade date
05 Oct '26
15 day traded volume
₹13.48 Cr
Avg. daily volume
₹90.00 L
Avg. daily trades
~3
Reflects all trades executed on NSE and BSE
Last updated on 13 Oct '26 at 4:00 AM
Financials
RevenueEBITDAPAT
Yearly
*All values are in cr
Company updates
News
Dishman Carbogen Amcis Ltd Hits Intraday High with 7.31% Surge on 3 Feb 2026•36 weeks ago
Dishman Carbogen Amcis Ltd recorded a robust intraday performance on 3 Feb 2026, surging 7.31% to touch a day’s high of Rs 233.5, significantly outperforming the broader market and its sector peers.
Samunnati raises Rs 2,300 Cr in FY25; expands lender base•79 weeks ago
Looking ahead, Samunnati has a debt pipeline exceeding Rs 600 crore for the first quarter of FY26, indicating continued momentum in its financing activity.
Other disclosures
Documents
Key information document
Rating report
Disclaimer: Bond details and related information displayed on this page are sourced from Deridata and other available sources and are provided for informational purposes. While BondScanner may review or validate certain information before displaying it, the information may be subject to change and should not be relied upon as the sole basis for any investment decision. Investors are advised to independently verify critical information from the relevant offer documents and other official sources before investing.
Source: Derivium Tradition India Securities Pvt Ltd.